Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phosphodiesterase-type 5 Inhibitors in Adult and Adolescent Patients With Univentricular Heart Disease: a Multi-center, Randomized, Double Blind Phase III Study

NCT03997097 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT03997097
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03997097 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phosphodiesterase-type 5 Inhibitors in Adult and Adolescent Patients With Univentricular Heart Disease: a Multi-center, Randomized, Double Blind Phase III Study
Lead sponsor
University Hospital, Montpellier
Phase
Phase 3
Overall status
Withdrawn
Start date
June 1, 2023
Completion date
June 1, 2028
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary hypertension, single-ventricle, univentricular heart